Results 111 to 120 of about 717 (150)

Long-Term Outcomes of Early Enzyme Replacement Therapy With Asfotase Alfa in Perinatal Benign Hypophosphatasia: Amelioration of Bone Deformities in a Young Child. [PDF]

Cureus
Terayama S, Kobayashi M, Suemitsu T, Samura O, Oishi K.   +4 more
europepmc   +1 more source

Longitudinal course of circulating miRNAs in a patient with hypophosphatasia and asfotase alfa treatment: a case report. [PDF]

JBMR Plus
Hadzimuratovic B, Haschka J, Hackl M, Diendorfer AB, Mittelbach A, Feurstein J, Zwerina J, Resch H, Kocijan R.   +8 more
europepmc   +1 more source

AN ADJUNCTIVE USE OF ASFOTASE ALFA AND ZOLEDRONIC ACID AFTER SPINAL SURGERY IN NEUROFIBROMATOSIS TYPE 1 RELATED DYSTROPHIC SCOLIOSIS. [PDF]

AACE Clin Case Rep, 2020
Harindhanavudhi T, Takahashi T, Petryk A, Polly DW.   +3 more
europepmc   +1 more source

Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report. [PDF]

Medicine (Baltimore), 2018
Freitas TQ, Franco AS, Pereira RMR.
europepmc   +1 more source

Asfotase Alfa: Interference with ALP-detection systems in immunoassays [PDF]

, 2018
Fraser, William D., Piec, Isabelle, Thompkins, Beatrice   +2 more
core  

Asfotase alfa for hypophosphatasia.

Australian prescriber
openaire   +1 more source

Hypophosphatasia-pathophysiological understanding, preclinical data looking beyond the skeleton, and upcoming treatments. [PDF]

J Bone Miner Res
Millán JL.
europepmc   +1 more source